# Evaluation of Antigen-specific T Cells in Patients With Antisynthetase Syndrome and Interstitial Lung Disease

> **NCT05984394** · — · RECRUITING · sponsor: **Central Hospital, Nancy, France** · enrollment: 24 (estimated)

## Conditions studied

- Antisynthetase Syndrome

## Interventions

- **DIAGNOSTIC_TEST:** BAL antigen-specific Th1 cells and Th17 cells, ILC and MAIT

## Key facts

- **NCT ID:** NCT05984394
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-26
- **Primary completion:** 2025-10-31
- **Final completion:** 2025-10-31
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2024-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05984394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05984394, "Evaluation of Antigen-specific T Cells in Patients With Antisynthetase Syndrome and Interstitial Lung Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05984394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*